(Q41941800)

14 October 2017

title

The effect of verapamil alone and in combination with trypanocides on multidrug-resistant Trypanosoma brucei brucei (English)

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

28 October 2022

main subject

Trypanosoma brucei

0 references

multiple drug resistance

1 reference

1 reference

R. Kaminsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685302

28 October 2022

E. Zweygarth

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685302

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1685302

28 October 2022

publication date

1 August 1991

1 reference

full work available at URL

14 October 2017

https://api.elsevier.com/content/article/PII:0001706X9190040Q?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

https://api.elsevier.com/content/article/PII:0001706X9190040Q?httpAccept=text/plain

28 October 2022

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

28 October 2022

1 reference

14 October 2017

volume

49

1 reference

14 October 2017

issue

3

1 reference

14 October 2017

page(s)

215-225

1 reference

Clinical pharmacokinetics of verapamil, nifedipine and diltiazem

14 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

The biochemistry of P-glycoprotein-mediated multidrug resistance

28 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Resistance to multiple chemotherapeutic agents in human cancer cells

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Feeder layer-free in vitro assay for screening antitrypanosomal compounds against Trypanosoma brucei brucei and T. b. evansi

28 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Trypanosoma brucei brucei: expression of drug resistance in vitro.

28 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance.

28 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Reversal of chloroquine resistance in Plasmodium falciparum by verapamil

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Reversal of drug resistance in Trypanosoma cruzi and Leishmania donovani by verapamil

28 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Multiple drug resistance in Trypanosoma vivax in the Tana River District of Kenya.

28 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

Efficacy of experimental trypanocidal compounds against a multiple drug-resistant Trypanosoma brucei brucei stock in mice

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0001-706X(91)90040-Q

28 October 2022

Identifiers

1 reference

14 October 2017

1 reference